Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Sandu Pharmaceuticals had annual revenue of 699.35M INR with 4.08% growth. Sandu Pharmaceuticals had revenue of 168.53M in the quarter ending March 31, 2026, with 19.79% growth.

• Revenue: 699.35M
• Revenue Growth: +4.08%
• P/S Ratio: 0.61
• Revenue / Employee: 2.31M
• Employees: 303
• Market Cap: 426.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	699.35M	27.42M	4.08%
Mar 31, 2025	671.92M	-883.00K	-0.13%
Mar 31, 2024	672.81M	19.32M	2.96%
Mar 31, 2023	653.49M	-1.52M	-0.23%
Mar 31, 2022	655.01M	67.45M	11.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error